We next posited that lymphodepletion with 5Gy TBI or chemotherapeutics, which can have toxic side effects in patients, could be bypassed in animals with established melanoma if they were transiently depleted of host CD4+ T cells, given a tripartite ACT therapy and then treated with LPS. This evidence concerns the gene CD4 and melanoma.